Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
Open accessAbstract
Extracellular vesicles (EVs) are cell-derived nanoparticles that facilitate transport of proteins, lipids, and genetic material, playing important roles in intracellular communication. They have remarkable potential as non-toxic and non-immunogenic nanocarriers for drug delivery to unreachable organs and tissues, in particular, the central nervous system (CNS). Herein, we developed a novel platform based on macrophage-derived EVs to treat Parkinson disease (PD). Specifically, we evaluated the therapeutic potential of EVs secreted by autologous macrophages that were transfected ex vivo to express glial-cell-line-derived neurotrophic factor (GDNF). EV-GDNF were collected from conditioned media of GDNF-transfected macrophages and characterized for GDNF content, size, charge, and expression of EV-specific proteins. The data revealed that, along with the encoded neurotrophic factor, EVs released by pre-transfected macrophages carry GDNF-encoding DNA. Four-month-old transgenic Parkin Q311(X)A mice were treated with EV-GDNF via intranasal administration, and the effect of this therapeutic intervention on locomotor functions was assessed over a year. Significant improvements in mobility, increases in neuronal survival, and decreases in neuroinflammation were found in PD mice treated with EV-GDNF. No offsite toxicity caused by EV-GDNF administration was detected. Overall, an EV-based approach can provide a versatile and potent therapeutic intervention for PD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GDNF-enriched EVs enhanced neuronal survival, decreased neuroinflammation, and improved motor performance in a Parkinson's disease animal model.
“GDNF-enriched EVs treated with transgenic Parkin Q311 (X) Intranasal injection of a mouse enhanced neuronal survival, decreased neuroinflammation, and improved motor performance in the Parkinson’s disease animal model [261].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [261]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Zhao, Y., Haney, M. J., Gupta, R., Bohnsack, J. P., He, Z., Kabanov, A. V., & Batrakova, E. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106867 · Cited by 144 · see citing works
Self-citationRetractedHaney, M. J., Zhao, Y., Harrison, E. B., Mahajan, V., Ahmed, S., He, Z., Suresh, P., Hingtgen, S., Klyachko, N. L., Mosley, R. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061852 · Cited by 143 · see citing works
Self-citationRetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766 · see citing works
Exosomes as drug delivery vehicles for Parkinson’s disease therapy
Haney, M. J., Klyachko, N. L., Zhao, Y., Gupta, R., Plotnikova, E. G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A. V., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.033 · Cited by 2,009 · see citing works
Self-citationSaraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Kim, M. S., Haney, M. J., Zhao, Y., Mahajan, V., Le‐Deygen, I. M., Klyachko, N. L., Inskoe, E., Piroyan, A., Sokolsky‐Papkov, M., Okolie, O., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.012 · Cited by 1,498 · see citing works
Self-citationGDNF: a Potent Survival Factor for Motoneurons Present in Peripheral Nerve and Muscle
Henderson, C. E., PHILLIPS, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M. P., Simmons, L. C., Moffet, B., Vandlen, R. A., Koliatsos, V. E., et al. (1994) · Science · doi:10.1126/science.7973664 · Cited by 1,273 · see citing works
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,122 · see citing works
Self-citationExosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy
Lee, Y., Andaloussi, S. E., & Wood, M. J. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds317 · Cited by 936 · see citing works
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884 · see citing works
Hemler, M. E. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.153609 · Cited by 831 · see citing works
Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., & Li, G. (2008) · Molecular Therapy · doi:10.1038/mt.2008.1 · Cited by 805 · see citing works
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Besse, B., Charrier, M., Lapierre, V., Dansin, É., Lantz, O. J., Planchard, D., Chevalier, T. L., Livartoski, A., Barlési, F., Laplanche, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1071008 · Cited by 802 · see citing works
Characteristics of Compounds that Cross the Blood-Brain Barrier
Banks, W. A. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s3 · Cited by 710 · see citing works
Kim, M. S., Haney, M. J., Zhao, Y., Yuan, D., Deygen, I., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.09.011 · Cited by 663 · see citing works
Self-citationBlood–Brain Barrier Pathophysiology in Traumatic Brain Injury
Chodobski, A., Zink, B. J., & Szmydynger‐Chodobska, J. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0125-x · Cited by 655 · see citing works
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607 · see citing works
Self-citationBatchelor, P., Liberatore, G. T., Wong, J. Y. F., Porritt, M. J., Frerichs, F., Donnan, G. A., & Howells, D. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-05-01708.1999 · Cited by 576 · see citing works
Peripheral cytokines profile in parkinson’s disease
Reale, M., Iarlori, C., Thomas, A., Gambi, D., Perfetti, B., Di Nicola, M., & Onofrj, M. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.003 · Cited by 547 · see citing works
Elucidation of Exosome Migration Across the Blood–Brain Barrier Model In Vitro
Chen, C. C., Liu, L., Ma, F., Wong, C. W., Guo, X. E., Chacko, J. V., Farhoodi, H. P., Zhang, S. X., Zimak, J., Ségaliny, A., et al. (2016) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-016-0458-3 · Cited by 537 · see citing works
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., & Karamanos, Y. (2020) · Cells · doi:10.3390/cells9040851 · Cited by 503 · see citing works
CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport
Pardridge, W. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051781.x · Cited by 460 · see citing works
Is nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439 · see citing works
Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
Bagno, L., Hatzistergos, K. E., Balkan, W., & Hare, J. M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.009 · Cited by 342 · see citing works
Suzuki, M., McHugh, J., Tork, C. A., Shelley, B., Klein, S. M., Aebischer, P., & Svendsen, C. N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000689 · Cited by 311 · see citing works
Whone, A., Luz, M., Boca, M., Woolley, M., Mooney, L., Dharia, S., Broadfoot, J., Cronin, D., Schroers, C., Barua, N. U., et al. (2019) · Brain · doi:10.1093/brain/awz023 · Cited by 282 · see citing works
Rozas, G., Guerra, M. J., & Labandeira-García, J. L. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(97)00034-2 · Cited by 275 · see citing works
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Dou, H., Destache, C. J., Morehead, J., Mosley, R. L., Boska, M. D., Kingsley, J. D., Gorantla, S., Poluektova, L. Y., Nelson, J. A., Chaubal, M. V., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253 · see citing works
Haney, M. J., Zhao, Y., Jin, Y. S., Li, S. M., Bagó, J. R., Klyachko, N. L., Kabanov, A. V., & Batrakova, E. V. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09884-9 · Cited by 246 · see citing works
Self-citationJanelidze, S., Hertze, J., Nägga, K., Nilsson, K., Nilsson, C., Wennström, M., van Westen, D., Blennow, K., Zetterberg, H., & Hansson, O. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.017 · Cited by 237 · see citing works
A Macrophage−Nanozyme Delivery System for Parkinson's Disease
Batrakova, E. V., Li, S., Reynolds, A. D., Mosley, R. L., Bronich, T. K., Kabanov, A. V., & Gendelman, H. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700184b · Cited by 209 · see citing works
Self-citationRecent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Patel, A., Patel, M., Yang, X., & Mitra, A. K. (2014) · Protein and Peptide Letters · doi:10.2174/0929866521666140807114240 · Cited by 209 · see citing works
Rocha, N. P., de Miranda, A. S., & Teixeira, A. L. (2015) · BioMed Research International · doi:10.1155/2015/628192 · Cited by 200 · see citing works
Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190 · see citing works
Self-citationProspects for exosomes in immunotherapy of cancer
Mignot, G., Roux, S., Théry, C., Segura, É., & Zitvogel, L. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00406.x · Cited by 185 · see citing works
Nitric Oxide and Reactive Oxygen Species in Parkinson's Disease
Tieu, K., Ischiropoulos, H., & Przedborski, S. (2003) · IUBMB Life · doi:10.1080/1521654032000114320 · Cited by 180 · see citing works
Lu, X., Fleming, S. M., Meurers, B. H., Ackerson, L. C., Mortazavi, F., Lo, V., Hernandez, D., Sulzer, D., Jackson, G. R., Maidment, N. T., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5351-08.2009 · Cited by 177 · see citing works
Carrier-mediated or specialized transport of drugs across the blood–brain barrier
Tsuji, A., & Tamai, I. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00084-2 · Cited by 174 · see citing works
Haney, M. J., Klyachko, N. L., Harrison, E. B., Zhao, Y., Kabanov, A. V., & Batrakova, E. V. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801271 · Cited by 151 · see citing works
Self-citationExosomes and the blood–brain Barrier: Implications for Neurological Diseases
Wood, M. J. A., O’Loughlin, A. J., & Lakhal, S. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.83 · Cited by 146 · see citing works
Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
Klyachko, N. L., Arzt, C. J., Li, S. M., Gololobova, O. A., & Batrakova, E. V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121171 · Cited by 132 · see citing works
Self-citationEketjäll, S., Fainzilber, M., Murray‐Rust, J., & Ibáñez, C. F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.5901 · Cited by 129 · see citing works
Fallon, J. K., Neubert, H., Hyland, R., Goosen, T. C., & Smith, P. C. (2013) · Journal of Proteome Research · doi:10.1021/pr4004213 · Cited by 123 · see citing works
Self-citationMacrophages Offer A Paradigm Switch for CNS Delivery of Therapeutic Proteins
Klyachko, N. L., Haney, M. J., Zhao, Y., Manickam, D. S., Mahajan, V., Suresh, P., Hingtgen, S. D., Mosley, R. L., Gendelman, H. E., Kabanov, A. V., et al. (2014) · Nanomedicine · doi:10.2217/nnm.13.115 · Cited by 92 · see citing works
Self-citationMesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges
Najar, M., Bouhtit, F., Melki, R., Afif, H., Hamal, A., Fahmi, H., Merimi, M., & Lagneaux, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050626 · Cited by 91 · see citing works
Kameda, M., Shingo, T., Takahashi, K., Muraoka, K., Kurozumi, K., Yasuhara, T., Maruo, T., Tsuboi, T., Uozumi, T., Matsui, T., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05776.x · Cited by 78 · see citing works
Development and Evaluation of a Novel Intranasal Spray for the Delivery of Amantadine
Lungare, S., Bowen, J., & Badhan, R. K. S. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.12.016 · Cited by 77 · see citing works
GDNF therapy for Parkinson’s disease
Hong, M. G. L., Mukhida, K., & Mendez, I. M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1125 · Cited by 64 · see citing works
Polyelectrolyte Complex Optimization for Macrophage Delivery of Redox Enzyme Nanoparticles
Zhao, Y., Haney, M. J., Klyachko, N. L., Li, S., Booth, S. L., Higginbotham, S. M., Jones, J., Zimmerman, M. C., Mosley, R. L., Kabanov, A. V., et al. (2010) · Nanomedicine · doi:10.2217/nnm.10.129 · Cited by 64 · see citing works
Self-citationHaney, M. J., Suresh, P., Zhao, Y., Kanmogne, G. D., Kadiu, I., Sokolsky‐Papkov, M., Klyachko, N. L., Mosley, R. L., Kabanov, A. V., Gendelman, H. E., et al. (2012) · Nanomedicine · doi:10.2217/nnm.11.156 · Cited by 58 · see citing works
Self-citationBiomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows
González‐Nieto, D., Fernández-Serra, R., Pérez‐Rigueiro, J., Panetsos, F., Martínez‐Murillo, R., & Guinea, G. V. (2020) · Cells · doi:10.3390/cells9051074 · Cited by 53 · see citing works
Zhao, Y., Haney, M. J., Jin, Y. S., Uvarov, O., Vinod, N., Lee, Y. Z., Langworthy, B., Fine, J. P., Rodriguez, M., El‐Hage, N., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.027 · Cited by 46 · see citing works
Self-citationGlial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease.
Yasuhara, T., Shingo, T., & Date, I. (2007) · PubMed · doi:10.18926/amo/32888 · Cited by 43 · see citing works
Wang, F., Kameda, M., Yasuhara, T., Tajiri, N., Kikuchi, Y., Liang, H., Tayra, J. T., Shinko, A., Wakamori, T., Agari, T., et al. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.05.019 · Cited by 41 · see citing works
Khatri, R., Fallon, J. K., Rementer, R. J. B., Kulick, N., Lee, C. R., & Smith, P. C. (2019) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2019.106590 · Cited by 39 · see citing works
Self-citationHaney, M. J., Zhao, Y., Jin, Y. S., & Batrakova, E. V. (2020) · Cells · doi:10.3390/cells9051273 · Cited by 38 · see citing works
Self-citationBanks, W. A., Niehoff, M. L., Ponzio, N. M., Erickson, M. A., & Zalcman, S. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-231 · Cited by 36 · see citing works
Haney, M. J., Zhao, Y., Fallon, J. K., Wang, Y., Li, S. M., Lentz, E. E., Erie, D. A., Smith, P. C., & Batrakova, E. V. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100064 · Cited by 24 · see citing works
Self-citationHayes, S. H., Liu, Q., Selvakumaran, S., Haney, M. J., Batrakova, E. V., Allman, B. L., Walton, P. A., Kiser, P. K., & Whitehead, S. N. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00390-6 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [55]Sangolkar S.S. Pitcairn G.R. Dalby R.N. Particle size determination of nasal drug delivery system: A review Crit. Rev. Ther. Drug Carr. Syst. 2012 17 66 73
Cited by
Sorted by citations
Extracellular vesicles: a rising star for therapeutics and drug delivery
Du, S., Guan, Y., Xie, A., Yan, Z., Gao, S., Li, W., Rao, L., Chen, X., & Chen, T. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01973-5 · Cited by 321 · see citing works
Strategies for Engineering of Extracellular Vesicles
Aleksandrovna, D. A., Emene, C. C., Barlev, N. A., & Gomzikova, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713247 · Cited by 83 · see citing works
Payandeh, Z., Tangruksa, B., Synnergren, J., Heydarkhan‐Hagvall, S., Nordin, J. Z., Andaloussi, S. E., Borén, J., Wiseman, J., Bohlooly‐Y, M., Lindfors, L., et al. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101302 · Cited by 65 · see citing works
Susa, F., Arpicco, S., Pirri, C. F., & Limongi, T. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070849 · Cited by 50 · see citing works
Breaking barriers in targeted Therapy: Advancing exosome Isolation, Engineering, and imaging
Kostyusheva, A., Romano, E., Yan, N., Lopus, M., Zamyatnin, A. A., & Parodi, A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115522 · Cited by 42 · see citing works
Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy
Zhang, F., Xu, Z., & Jolly, K. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114827 · Cited by 32 · see citing works
Sánchez, S. V., Otavalo, G. N., Gazeau, F., Silva, A. K. A., & Morales, J. O. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.018 · Cited by 28 · see citing works
Immune cells: potential carriers or agents for drug delivery to the central nervous system
Zhang, S., Li, R.-Q., Chen, Z., Wang, X., Dumont, A. S., & Fan, X. (2024) · Military Medical Research · doi:10.1186/s40779-024-00521-y · Cited by 27 · see citing works
Mashele, S. S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17081082 · Cited by 27 · see citing works
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26 · see citing works
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration
Wu, H., Li, C., Yuan, H., Zhao, J., & Li, S. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s520768 · Cited by 25 · see citing works
Extracellular vesicle as therapeutic agents in anti-aging: Mechanistic insights and future potential
Yoon, H., Jo, J., Hyun, H., Lee, G., Ma, S., Sohn, J., Sung, D. K., Han, C. Y., Kim, M., Hwang, D., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113796 · Cited by 17 · see citing works
Uncovering Novel Therapeutic Targets for Parkinson’s Disease
Soni, R., Delvadia, P., Joharapurkar, A. A., & Shah, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00084 · Cited by 17 · see citing works
Extracellular particles: emerging insights into central nervous system diseases
Chen, S., Bao, Q., Xu, W., & Zhai, X. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03354-6 · Cited by 18 · see citing works
Palacio, P. L., Pleet, M. L., Reátegui, E., & Magaña, S. M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578064 · Cited by 18 · see citing works
Cationized extracellular vesicles for gene delivery
Klyachko, N. L., Haney, M. J., Lopukhov, A. V., & Le‐Deygen, I. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-75985-y · Cited by 12 · see citing works
Self-citationZhang, T., Liu, Z., Wei, Y., Lu, J., He, Z., Wu, Z., Liu, M., Li, K., Wang, X., Li, Z., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161653 · Cited by 14 · see citing works
Zhang, S., Li, J., Hu, X., Liu, H., Yu, Q., Kuang, G., Liu, L., Yu, D., Lin, Z., & Xiong, N. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01262 · Cited by 11 · see citing works
El‐Hage, N., Haney, M. J., Zhao, Y., Rodriguez, M., Wu, Z., Liu, M., Swain, C. J., Yuan, H., & Batrakova, E. V. (2023) · Cells · doi:10.3390/cells12111497 · Cited by 11 · see citing works
Self-citationEndogenous GDNF Is Unable to Halt Dopaminergic Injury Triggered by Microglial Activation
Mendes‐Oliveira, J., Campos, F. L., Ferreira, S. A., Tomé, D., Fonseca, C. P., & Baltazar, G. (2023) · Cells · doi:10.3390/cells13010074 · Cited by 10 · see citing works
Wagh, S. S., Famta, P., Shah, S., Vambhurkar, G. B., Pandey, G., Sikder, A., Singh, G., Shukla, S., Sharma, A., Prasad, S. B., et al. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101040 · Cited by 10 · see citing works
Ding, Y., Zhang, Y., & Liu, X. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1043947 · Cited by 5 · see citing works
Fu, J., Huang, S., Zhang, A., Shi, R., Wei, Y., He, S., Huang, S., Li, L., Sun, X., Gong, T., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101413 · Cited by 3 · see citing works
Insights into the Versatile Role of Extracellular Vesicles in the Treatment of CNS Disorders
Jana, K., Ghosh, S., Parua, P., Debnath, B., Halder, J., Sahoo, R. K., Rai, V. K., Pradhan, D., Dash, P., Das, C., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05283-9 · Cited by 3 · see citing works
Genetically Mediated Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications
Tollabi, M., Kheirandish, M. H., Mehrabi, A., Poursalehi, Z., Heidari, M., & Milan, P. B. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_6 · Cited by 2 · see citing works
Nanoparticle-Mediated Gene Therapy for Neurological Disorders
Modi, C. D., Arora, M., Dudhatra, B., Singh, A. K., Udhwani, N. H., Rana, H., & Prajapati, B. G. (2025) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-80185-3_2 · Cited by 1 · see citing works
Cell-based immunotherapy for neurodegenerative disease: A promising avenue
Huerta, T. J., Urbina-Muñoz, V., Urra-Alvarez, V., Villablanca, C., Gómez‐Pérez, L. S., Saavedra, B., Contreras, T., & Vidal, R. L. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00816 · Cited by 1 · see citing works
The role of GDNF in neurodegenerative pathologies
Kolesnikova, A., Ushakova, V. M., Zorkina, Y., Andriushchenko, A., Zubkov, E. A., Chekhonin, V. P., & Kostyuk, G. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00234-z · Cited by 1 · see citing works
Autonomous intranasal delivery systems for central nervous system therapeutics
Shen, H., Srivastava, S. K., Aggarwal, N., & Chang, M. W. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01781-5 · Cited by 1 · see citing works
Engineering Cell Membrane-Derived Nanovesicles for Advanced Biomedical Applications
Hussain, Z., Ahmed, W., Gao, T., Zhang, Y., & Pei, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_2
Rajeshkumar, R. R., Pandi, J. S., Murugesan, S., Pavadai, P., Theivendren, P., & Kunjiappan, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_16
Lafarge, E., Dowd, E., & McKernan, D. P. (2026) · International Journal of Polymeric Materials · doi:10.1080/00914037.2025.2610718
Role of astrocytes in the development and progression of major depressive disorder
Jing, P., Sun, C., Xiao-peng, Y. I. N., Liu, X.-C., Tian, Q., & (673328), X.-B. Z. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i5.115794
Functionalization of extracellular vesicles for biomedical applications
Rani, S., Hussain, Z., & Pei, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00009-7
Raut, N. G. R., Sprague, K. L., Adlakha, A., Rupert, A. R., Hofmann, M. C., Queme, L. F., Ratner, N., & Jankowski, M. P. (2026) · Science Signaling · doi:10.1126/scisignal.aee5174
Microglial advances in Parkinson’s disease
Debasa‐Mouce, M., Ouro, A., Leon, J. D., Gulkarov, S., Reiss, A. B., & Bougea, A. M. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.06.003
Kingsley, C., Ahad, N., Rodriguez, K., & Xiang, A. Q. (2026) · Research Square · doi:10.21203/rs.3.rs-10308858/v1
Xiang, A. Q., Kingsley, C., Ahad, N., & Rodriguez, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10308858/v2
Xiang, A. Q., Kingsley, C., Ahad, N., & Rodriguez, K. (2026) · Research Square · doi:10.21203/rs.3.rs-10308858/v3
- Authors
- Zhao, Y., Haney, M. J., Fallon, J. K., Rodriguez, M., Swain, C. J., Arzt, C. J., Smith, P. C., Loop, M. S., Harrison, E. B., El-Hage, N., & Batrakova, E. V.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Florida International University (US)
- Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA
- Corresponding author
- Batrakova, Elena V.
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-06-15
- Volume
- 11
- Issue
- 12
- Pages
- 1933
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC9222008
- OpenAlex
- W4282975617
- Cited by
- 39
- References
- 60
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 5 · 2023: 7 · 2022: 1
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (1RO1 NS102412, 1R01NS112019-01A1, EII UNC 38-124)
- Eshelman Institute for Innovation (1RO1 NS102412, 1R01NS112019-01A1, EII UNC 38-124)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- extracellular vesicles, Parkinson's disease, glial cell line-derived neurotrophic factor, macrophages, intranasal drug delivery, neuroprotection, neuroinflammation, locomotor function, nanocarriers
- MeSH terms
- Extracellular Vesicles, Animals, Central Nervous System, Macrophages, Parkinson Disease, Glial Cell Line-Derived Neurotrophic Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review